Searched for
LUPIN PRESIDENT
Doing more with less is India Inc's new mantra to beat tough timesPrioritising efficiency, Indian enterprises are reshaping their spending habits. Non-essential travel and expenses are being minimized, whi...- Lupin inks licensing pact with Neopharmed for Plasil brand in Philippines, BrazilPharma major Lupin Limited has secured exclusive marketing rights for the gastroenterology brand Plasil in the Philippines and Brazil. Subs...
- Lupin ties up with Sandoz to commercialise biosimilar productLupin has partnered with Sandoz Group AG to commercialize its biosimilar ranibizumab across multiple regions, with Sandoz handling commerci...
- Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global marketsLupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The agreement grants...
- Lupin inks pact with China's Sino Universal Pharmaceuticals for Tiotropium dry powder inhalerLupin Limited partners with Sino Universal Pharmaceuticals. They will commercialize Tiotropium dry powder inhaler in China. This inhaler tr...
- Lupin inks licensing deal to supply biosimilar ranibizumab in Latin AmericaLupin, an Indian drug maker, partners with SteinCares. The agreement focuses on ranibizumab's commercialisation. Latin America, excluding M...
- Lupin acquires UK-based firm for 12.3 million poundsLupin has acquired UK-based Renascience Pharma for £12.3 million, enhancing its branded medicine portfolio. The acquisition allows Lupin to...
- Lupin subsidiary acquires 9 brands South African firmLupin's subsidiary, in partnership with ImpiloVest, has acquired nine brands from MNI in South Africa, enhancing its portfolio in complemen...
- Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian marketLupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The ...
- Lupin to acquire French firm Medisol for around Rs 160 crPharmaceuticals firm Lupin Ltd on Friday said it will fully acquire French pharmaceutical company Medisol for 18 million euros (over Rs 160...
- Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tabletsThe tentative approval by the United States Food and Drug Administration (USFDA) has been granted under the President's emergency plan for ...
- Lupin appoints Spiro Gavaris as president of US generics bizSpiro, who had most recently served as president of Specialty Generics business at Mallinckrodt Pharmaceuticals and the president of US Inj...
- Lupin inks pact with Shenzhen Foncoo to introduce products in ChinaThe company would continue to explore additional partnership opportunities in China to leverage its global portfolio including complex gene...
- Lupin gets USFDA nod for HIV drug under PEPFARLupin got a green signal from the US health regulator to sell HIV drug in the American market. The product that has received a nod under US...
- Lupin hire Nicholas Hart to head US businessHis past experiences include Business Unit Head for Reproductive Health at Ferring Pharmaceuticals, Inc and Senior Vice President of Sales ...
- Lupin arm in pact to distribute anti-depressant drug in JapanLupin President Dr. Fabrice Egros said the Astellas agreement reinforces Kyowa's transition toward a hybrid pharmaceutical specialty care c...
- Lupin appoints Thierry Volle as President of EMEA businessDrug major Lupin has appointed Thierry Volle as President of Europe, the Middle-East & Africa (EMEA) with immediate effect based at the com...
- Lupin on buying spree; to acquire German company Temmler Pharma's product portfolioA day after announcing its biggest acquisition deal of $880 million, Lupin today said it will buy Germany-based Temmler Pharma's specialty ...
- Lupin joins hands with FOGSIPharma major Lupin has joined hands with Federation of Obstetric and Gynaecological Socities of India (FOGSI) to launch 'Save the Girl Chil...
- Lupin appoints Swaminathan as PresidentPharma company Lupin Limited appoints Ramesh Swaminathan as its President for finance and planning.
Load More
